Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

997 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Year of Child Injury Prevention on Instagram.
Manganello JA, Kane C, Roberts K, Klein EG, McAdams RJ, McKenzie LB. Manganello JA, et al. Among authors: kane c. J Health Commun. 2021 Sep 2;26(9):636-644. doi: 10.1080/10810730.2021.1985658. Epub 2021 Oct 11. J Health Commun. 2021. PMID: 34632948
Laws for health and care worker protection and rights: A study of 182 countries.
Kavanagh MM, Radakrishnan A, Unnikrishnan V, Cometto G, Kane C, Friedman EA, Srivatsan V, Abinader LG, Campbell J; Health & Care Worker Policy Lab. Kavanagh MM, et al. Among authors: kane c. PLOS Glob Public Health. 2024 Dec 9;4(12):e0003767. doi: 10.1371/journal.pgph.0003767. eCollection 2024. PLOS Glob Public Health. 2024. PMID: 39652521 Free PMC article.
Germline genetic testing for prostate cancer: Ordering trends in the era of expanded hereditary cancer screening recommendations.
Roberts JL, Wang LL, Rose B, Seibert TM, Madlensky L, Nielsen SM, Salmasi A, Kader AK, Kane CJ, Crawford ED, Javier-Desloges J, McKay RR, Bagrodia A. Roberts JL, et al. Among authors: kane cj. Urol Oncol. 2024 Oct 30:S1078-1439(24)00690-2. doi: 10.1016/j.urolonc.2024.10.010. Online ahead of print. Urol Oncol. 2024. PMID: 39482144
Unusual holopelagic Sargassum mass beaching in Northwest Africa: Morphotypes, chemical composition, and potential valorisation.
Bousso NC, Brehmer P, Ndiaye W, Stiger-Pouvreau V, Kane C, Gautier M, Faye M, Fricke A, Diadhiou HD, Aroui Boukbida H, Weinberger F, Ramasamy B, Diedhiou F, Diop MS, Balde BS, Simon G, Quack B. Bousso NC, et al. Among authors: kane c. Sci Total Environ. 2024 Dec 10;955:177018. doi: 10.1016/j.scitotenv.2024.177018. Epub 2024 Oct 21. Sci Total Environ. 2024. PMID: 39437924
Evaluation of Drug-Drug Interaction Potential of Talquetamab, a T-Cell-Redirecting GPRC5D × CD3 Bispecific Antibody, as a Result of Cytokine Release Syndrome in Patients with Relapsed/Refractory Multiple Myeloma in MonumenTAL-1, Using a Physiologically Based Pharmacokinetic Model.
Willemin ME, Gong J, Hilder BW, Masterson T, Tolbert J, Renaud T, Heuck C, Kane C, De Zwart L, Girgis S, Ma X, Ouellet D. Willemin ME, et al. Among authors: kane c. Target Oncol. 2024 Nov;19(6):965-979. doi: 10.1007/s11523-024-01093-6. Epub 2024 Sep 16. Target Oncol. 2024. PMID: 39285155 Free PMC article. Clinical Trial.
Talquetamab Versus Real-World Physician's Choice Treatment: Comparative Effectiveness in Patients With Triple-Class Exposed Relapsed/Refractory Multiple Myeloma.
Ye JC, Biran N, Nair S, Lin X, Qi K, Londhe A, Ammann E, Renaud T, Kane C, Parekh T, Gray K, Peterson S, Costa LJ. Ye JC, et al. Among authors: kane c. Clin Lymphoma Myeloma Leuk. 2024 Aug 13:S2152-2650(24)00295-7. doi: 10.1016/j.clml.2024.08.003. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39271448
Matching-adjusted indirect comparison of talquetamab vs selinexor-dexamethasone and vs belantamab mafodotin in patients with relapsed/refractory multiple myeloma.
Reece D, Diels J, Van Sanden S, Pei L, Ammann E, Heuck C, Kane C, Londhe A, Peterson S, Chari A. Reece D, et al. Among authors: kane c. Curr Med Res Opin. 2024 Oct;40(10):1769-1783. doi: 10.1080/03007995.2024.2391553. Epub 2024 Sep 3. Curr Med Res Opin. 2024. PMID: 39226081 Free article. Clinical Trial.
997 results